Literature DB >> 29777272

Modified extraperitoneal uterosacral ligament suspension for prevention of vault prolapse after vaginal hysterectomy.

Manidip Pal1,2, Soma Bandyopadhyay3.   

Abstract

INTRODUCTION AND HYPOTHESIS: During vaginal hysterectomy, extraperitoneal uterosacral ligament suspension (ULS) bites can be taken before removing the uterus. We evaluated this modified extraperitoneal ULS for vault prolapse prevention.
METHODS: Study period was 3.5 years. Fifty-one women with third- and fourth-degree prolapse were enrolled. An inverted V incision was made on the anterior vaginal wall and continued as a semicircular incision on the posterior vaginal wall. Lateral vaginal mucosa was pushed up to expose the cardinal-uterosacral ligament complex. The first ULS suture, using polypropylene no. 1, was taken in the upper-most exposed area of the uterosacral ligament. The second suture, using polyglactin no. 1 or 0, was taken 0.5-1 cm below the first suture. During placement of both sutures, traction on the cervix was maintained. The cardinal-uterosacral ligament complex was clamped, dissected, and ligated 1 cm below the second suture. Vaginal hysterectomy was completed. Ends of the ULS suture were fastened to the vault via vesicovaginal and rectovaginal septum using polypropylene within and polyglactin outside vaginal mucosa.
RESULTS: Prolapse stage was 3 in 42 cases and 4 in nine. Duration of operation ranged from 60 to 120 min. Blood loss was 100-300 ml. During follow-up (average 2.3 years) four (8.3%), cases had stage 1 pelvic organ prolapse (POP), three were lost to follow-up, and 44 (91.6%) had no POP.
CONCLUSIONS: Using the cervix as a traction device is a good option when performing extraperitoneal ULS during vaginal hysterectomy to prevent vault prolapse.

Entities:  

Keywords:  Polyglactin; Polypropylene; Recurrence; Vaginal hysterectomy

Mesh:

Year:  2018        PMID: 29777272     DOI: 10.1007/s00192-018-3669-4

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  7 in total

Review 1.  Uterosacral ligament vaginal vault suspension: anatomy, outcome and surgical considerations.

Authors:  Taji Yazdany; Narender Bhatia
Journal:  Curr Opin Obstet Gynecol       Date:  2008-10       Impact factor: 1.927

2.  Permanent suture used in uterosacral ligament suspension offers better anatomical support than delayed absorbable suture.

Authors:  Christopher P Chung; Richard Miskimins; Thomas J Kuehl; Paul M Yandell; Bobby L Shull
Journal:  Int Urogynecol J       Date:  2011-09-03       Impact factor: 2.894

Review 3.  Surgical management of pelvic organ prolapse: abdominal and vaginal approaches.

Authors:  Kristina Cvach; Peter Dwyer
Journal:  World J Urol       Date:  2011-10-22       Impact factor: 4.226

4.  A transvaginal approach to repair of apical and other associated sites of pelvic organ prolapse with uterosacral ligaments.

Authors:  B L Shull; C Bachofen; K W Coates; T J Kuehl
Journal:  Am J Obstet Gynecol       Date:  2000-12       Impact factor: 8.661

5.  Technique of extraperitoneal uterosacral ligament suspension for apical suspension.

Authors:  Lin L Ow; Caroline E Walsh; Natarajan Rajamaheswari; Peter L Dwyer
Journal:  Int Urogynecol J       Date:  2015-11-26       Impact factor: 2.894

6.  Bilateral extraperitoneal uterosacral suspension: a new approach to correct posthysterectomy vaginal vault prolapse.

Authors:  Peter L Dwyer; Brigitte Fatton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-08-10

7.  Bilateral extraperitoneal uterosacral vaginal vault suspension: a 2-year follow-up longitudinal case series of 123 patients.

Authors:  Brigitte Fatton; Peter L Dwyer; Chahin Achtari; P K Tan
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-01-22
  7 in total
  1 in total

1.  Video of uterovaginal procidentia repair incorporating a high extraperitoneal uterosacral vault suspension.

Authors:  Ariel Zilberlicht; Peter L Dwyer; Natarajan Rajamaheswari; Nicola Dykes; Debjyoti Karmakar
Journal:  Int Urogynecol J       Date:  2020-04-21       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.